v3.26.1
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations and comprehensive loss as follows:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

 

(In thousands)

 

Research and development

 

$

9,443

 

 

$

14,059

 

 

$

17,025

 

 

$

26,685

 

General and administrative

 

 

8,632

 

 

 

7,977

 

 

 

14,529

 

 

 

17,191

 

Total

 

$

18,075

 

 

$

22,036

 

 

$

31,554

 

 

$

43,876

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Summary of Restricted Stock Activity

The following table summarizes the Company’s RSU activity for the six months ended June 30, 2026:

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair Value
per Share

 

Unvested restricted stock units as of December 31, 2025

 

 

5,196,121

 

 

$

22.80

 

Granted

 

 

3,233,769

 

 

 

14.51

 

Vested

 

 

(1,637,518

)

 

 

24.69

 

Cancelled

 

 

(374,201

)

 

 

33.85

 

Unvested restricted stock units as of June 30, 2026

 

 

6,418,171

 

 

$

17.50

 

Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted Weighted average assumptions used to apply this pricing model were as follows:

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2026

 

2025

 

2026

 

2025

Risk-free interest rate

 

4.3%

 

4.1%

 

3.7%

 

4.1%

Expected term

 

5.5 years

 

5.5 years

 

5.9 years

 

5.9 years

Expected volatility of underlying stock

 

82.4%

 

79.4%

 

83.6%

 

75.8%

Expected dividend yield

 

0.0%

 

0.0%

 

0.0%

 

0.0%

Summary of Stock Option Activity

The following is a summary of stock option activity for the six months ended June 30, 2026:

 

 

Number of
Options

 

 

Weighted
Average
Exercise
Price per
Share

 

 

Weighted
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(In years)

 

 

(In thousands)

 

Outstanding at December 31, 2025

 

 

5,173,766

 

 

$

39.98

 

 

 

5.97

 

 

$

50

 

Granted

 

 

824,581

 

 

 

13.68

 

 

 

 

 

 

 

Exercised

 

 

(1,250

)

 

 

13.40

 

 

 

 

 

 

 

Forfeited

 

 

(276,381

)

 

 

32.45

 

 

 

 

 

 

 

Outstanding at June 30, 2026

 

 

5,720,716

 

 

$

36.56

 

 

 

6.11

 

 

$

11,854

 

Exercisable at June 30, 2026

 

 

4,328,122

 

 

$

43.64

 

 

 

5.12

 

 

$

6,429

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 Employee Stock Purchase Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Weighted Average Assumptions Used to Compute Fair Value of Option Granted

The fair value of shares under the 2016 Plan was estimated at the beginning of the offering period using a Black-Scholes option-pricing model with the following assumptions:

 

 

Three and Six Months Ended June 30,

 

 

 

2026

 

2025

 

Risk-free interest rate

 

3.59%

 

4.24%

 

Expected term

 

0.5 years

 

0.5 years

 

Expected volatility of underlying stock

 

121.1%

 

66.2%

 

Expected dividend yield

 

0.0%

 

0.0%